Makers Labs. (506919)
Score breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 2/2 · Dividend: 0/1
Key Financials
| Current Price | ₹135.3 |
| Market Cap | ₹83.9 Cr |
| P/E Ratio | 70.75 |
| ROCE | 4.25% |
| ROE | -3.7% |
| Dividend Yield | 0% |
| Profit Growth | 413.33% |
| Debt/Equity | — |
| Sales Growth | 28.82% |
| 52-Week Range | ₹109 — ₹186.7 |
| Sector | Pharmaceuticals & Biotechnology |
| Book Value | ₹100.21 |
AI Analysis
AI-generated, general educational analysis — not personal investment advice.
Let me forget the name and just look at the numbers. Makers Labs is a small ₹84 Cr pharmaceutical company. I am being asked to pay ₹135.30 a share, or 1.35 times book, for a business whose book value is ₹100.21. That does not look crazy on the asset side. But look at earnings: a trailing P/E of 70.75 means the company earned only about ₹1.2 Cr over the past year. For that, I need a very confident view of the future.
The full AI analysis, bull and bear case and key monitorables are in FairStock Pro.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer